A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer

NCT01710592 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NETWORK

Sponsor class

Conditions

Gastro Oesophageal Cancer

Interventions

DRUG: Epirubicin
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Docetaxel

Sponsor

Cancer Trials Ireland